News Digest / Ticker: AGTX

Ticker: AGTX

06:01pm, Friday, Aug 22, 2025

Agentix Corp. warns of going-concern as cash falls to $4,412 despite rising R&D

Agentix Corp. (PINK: AGTX) - Quick take Agentix Corp. is a clinical-stage biotech with no reported revenue for the quarter ended June 30, 2025. The quarter shows rising R&D activity but weak liquidity, significant related‑party funding and a formal going‑concern disclosure. Key facts & figures * ...

02:31pm, Tuesday, Feb 18, 2025

Agentix Corp. Reports Increased Losses and Rising Expenses Amidst Financial Challenges